Astrocytoma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
! colspan="2" rowspan="4" |Diseases | ! colspan="2" rowspan="4" |Diseases | ||
| colspan="7" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | | colspan="7" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | ||
! colspan=" | ! colspan="3" rowspan="2" |Para-clinical findings | ||
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | | colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
Line 18: | Line 18: | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! | !Imaging | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunohistopathology | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunohistopathology | ||
|- | |- | ||
Line 29: | Line 29: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Focal neurologic deficit | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Focal neurologic deficit | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Endocrine abnormalities/? | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Endocrine abnormalities/? | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ||
|- | |- | ||
Line 42: | Line 41: | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Supratentorial | * Supratentorial | ||
Line 80: | Line 78: | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Almost always in cerebral hemisphers (frontal lobes) | * Almost always in cerebral hemisphers (frontal lobes) | ||
Line 110: | Line 107: | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Well circumscribed | * Well circumscribed | ||
Line 141: | Line 137: | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Infratentorial | * Infratentorial | ||
Line 166: | Line 161: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Endocrine abnormalities as a result of functional adenomas or pressure effect of non-functional adenomas | * Endocrine abnormalities as a result of functional adenomas or pressure effect of non-functional adenomas | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Isointense to normal pituitary gland in T1 | * Isointense to normal pituitary gland in T1 | ||
Line 189: | Line 183: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Split-fat sign | * Split-fat sign | ||
Line 212: | Line 205: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Usually deep in the [[white matter]] | * Usually deep in the [[white matter]] | ||
Line 238: | Line 230: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Infratentorial | * Infratentorial | ||
Line 264: | Line 255: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Infratentorial | * Infratentorial | ||
Line 289: | Line 279: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Infratentorial | * Infratentorial | ||
Line 316: | Line 305: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Hypopituitarism as a result of pressure effect on pituitary gland | * Hypopituitarism as a result of pressure effect on pituitary gland | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Calcification | * Calcification | ||
Line 340: | Line 328: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* + B-hCG rise leads to precocious puberty in males | * + B-hCG rise leads to precocious puberty in males | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Hydrochepalus (compression of cerebral aqueduct) | * Hydrochepalus (compression of cerebral aqueduct) | ||
Line 359: | Line 346: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Supratentorial: ~85% | * Supratentorial: ~85% | ||
Line 369: | Line 354: | ||
* Angiography | * Angiography | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* We may see bag of worms" appearance in CT angiography | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain aneurysm | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain aneurysm | ||
Line 379: | Line 365: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* In magnetic resonance angiography, we may see aneurysm mostly in anterior circulation (~85%) | * In magnetic resonance angiography, we may see aneurysm mostly in anterior circulation (~85%) | ||
Line 403: | Line 387: | ||
* Elevated ESR | * Elevated ESR | ||
* Blood culture may be positive for underlying organism | * Blood culture may be positive for underlying organism | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Central hypodense signal and surrounding ring-enhancement in T1 | * Central hypodense signal and surrounding ring-enhancement in T1 | ||
Line 425: | Line 406: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Hydrocephalus combined with marked basilar meningeal enhancement | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 432: | Line 413: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Toxoplasmosis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Toxoplasmosis | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 449: | Line 429: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hydatid cyst | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Hydatid cyst | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 466: | Line 445: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Fungal | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Fungal | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 482: | Line 460: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain metastasis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain metastasis | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 16:02, 21 January 2019
Astrocytoma Microchapters |
Diagnosis |
---|
Treatment |
Case Study |
Astrocytoma differential diagnosis On the Web |
American Roentgen Ray Society Images of Astrocytoma differential diagnosis |
Risk calculators and risk factors for Astrocytoma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Differentiating astrocytoma from other Diseases
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||
Lab Findings | Imaging | Immunohistopathology | |||||||||||
Headache | Seizure | Visual disturbance | Hearing loss | Constitutional | Extraocular movement disorder | Focal neurologic deficit | Endocrine abnormalities/? | MRI | |||||
Adult primary brain tumors | Glioblastoma multiforme | + | +/− | +/− | − | − | + | − |
|
|
|
| |
Oligodendroglioma | + | + | +/− | − | − | + | − |
|
|
|
| ||
Meningioma | + | +/− | +/− | − | − | + | − |
|
|
|
| ||
Hemangioblastoma | + | +/− | +/− | − | − | + | − |
|
|
|
| ||
Pituitary adenoma | − | − | + Bitemporal hemianopia | − | − | − |
|
|
|
|
| ||
Schwannoma | − | − | +/− | + | − | − |
|
|
|
| |||
Primary CNS lymphoma | + | +/− | +/− | − | − | − |
|
|
|
| |||
Childhood primary brain tumors | Pilocytic astrocytoma | + | +/− | +/− | − | − | − |
|
|
|
| ||
Medulloblastoma | + | +/− | +/− | − | − | − |
|
|
|
| |||
Ependymoma | + | +/− | +/− | − | − | − |
|
|
|
| |||
Craniopharyngioma | + | +/− | + Bitemporal hemianopia | − | − |
|
|
|
|
| |||
Pinealoma | + | +/− | +/− | − | − | + vertical gaze palsy | + |
|
|
|
|
||
Vascular | AV malformation | + | + | − |
|
|
|
| |||||
Brain aneurysm | + | − |
|
|
|
| |||||||
Infectious | Bacterial brain abscess | + | + |
|
|
|
|
||||||
Tuberculosis | + | + |
|
||||||||||
Toxoplasmosis | + |
|
|||||||||||
Hydatid cyst | + |
|
|||||||||||
Fungal | + | ||||||||||||
Other | Brain metastasis | + |
|
|
|
|